The World Health Organization (WHO) announced on Friday that the first patients for its Solidarity trial have enrolled in Norway and Spain. The trial will examine potential treatment options for coronavirus disease 2019 (COVID-19).
The trial is organized in such a way that the WHO is able to test different treatment approaches across several countries. This is done in order to compare data measuring the effectiveness of each treatment.
“We are delighted to announce that today in Norway and Spain, the first patients will shortly be enrolled in the Solidarity trial, which will compare the safety and effectiveness of four different drugs or drug combinations against Covid-19,” WHO Director-General Tedros Adhanom Ghebreyesus said.
“This is a historic trial which will dramatically cut the time needed to generate robust evidence about what drugs work. Over 45 countries are contributing to the trial and more have expressed interest,” he continued. “The more countries who join the trial, the faster we will have results.”
According to the WHO, several countries including Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland, and Thailand have shown interest in participating in the trial.
What do you think about this?
Do you have a story for the WhenInManila.com Team? Email us at firstname.lastname@example.org or send us a direct message at WhenInManila.com Facebook Page. Interact with the team and join the WhenInManila.com Community at WIM Squad!